ONL Therapeutics' Seed Round

ONL Therapeutics raised a round of funding on June 30, 2014. Investors include Capital Community Angels.

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. Existing therapies have significant limitations and none address the initial ne…

Articles about ONL Therapeutics' Seed Round: